Christophe Bonny

Room 907, Tsinghua High Tech Park
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A novel bile salt hydrolase-producing Ligilactobacillus salivarius prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration.

A novel bile salt hydrolase-producing Ligilactobacillus salivarius prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration.

Journal: Gut microbes

Published: May 07, 2026

EB1010, a putative Christensenellaceae-derived microbial peptide, exhibits anti-inflammatory activity and therapeutic potential in ulcerative colitis.

EB1010, a putative Christensenellaceae-derived microbial peptide, exhibits anti-inflammatory activity and therapeutic potential in ulcerative colitis.

Journal: Gut microbes

Published: April 25, 2026

Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study.

Fecal microbiota transplantation combined with anti-PD-1 therapy in refractory microsatellite-stable gastric cancer: a phase I feasibility and safety study.

Journal: Journal for immunotherapy of cancer

Published: February 21, 2026

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Journal: Journal for immunotherapy of cancer

Published: January 28, 2025

Identification of a muropeptide precursor transporter from gut microbiota and its role in preventing intestinal inflammation.

Identification of a muropeptide precursor transporter from gut microbiota and its role in preventing intestinal inflammation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 21, 2023

Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation.

Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation.

Journal: JCI insight

Published: February 16, 2022

Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease.

Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease.

Journal: Journal of gastroenterology and hepatology

Published: September 22, 2021

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease.

Journal: Microbiome

Published: April 27, 2021

GeneMark-HM: improving gene prediction in DNA sequences of human microbiome.

GeneMark-HM: improving gene prediction in DNA sequences of human microbiome.

Journal: NAR genomics and bioinformatics

Published: November 22, 2020

Impact of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy on gut microbiota: a metagenomic comparative analysis.

Impact of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy on gut microbiota: a metagenomic comparative analysis.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

Published: October 24, 2019

Title Not Found

Title Not Found

Journal: Therapie

Published: December 19, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026